Patents by Inventor Vamsee Krishna
Vamsee Krishna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10579558Abstract: A redundancy termination panel includes first and second interfaces configured to be coupled to first and second I/O modules, respectively. The redundancy termination panel also includes a third interface configured to be coupled to a field device. The redundancy termination panel further includes an I/O channel circuit associated with an I/O channel between the I/O modules and the field device. The I/O channel circuit is configured to allow an input current used for receiving data from the field device to be split such that different portions of the input current are sourced by different ones of the I/O modules. The I/O channel circuit is also configured to combine multiple currents driven by different ones of the I/O modules and provide an output current used for sending data to the field device.Type: GrantFiled: March 6, 2019Date of Patent: March 3, 2020Assignee: Honeywell International Inc.Inventors: Nagaraja Sundaresh, Vamsee Krishna Aradhyula, Ram Mohan Anugu, Shripad Kumar Pande
-
Patent number: 10558746Abstract: With the scale of information available today along with the existing diverse channels of communication, manual processing of information is becoming a challenge and companies across industries are under tremendous pressure to lower transactional costs. Artificial Intelligence based automation of business transactions has seen regulatory hurdles due to probabilistic nature of the outcome. The main challenge lies in processing of transactions with unstructured information. Systems and methods of the present disclosure uses deterministic as well as probabilistic approaches to maximize accuracy. The larger use of deterministic approach with configurable components and ontologies helps to improvise accuracy, precision and reduce recall. The probabilistic approach is used when there is absence of quality information or less information for learning. Also, confidence indicators are provided at attribute level of data being processed and at each decision level.Type: GrantFiled: March 26, 2018Date of Patent: February 11, 2020Assignee: Tata Consultancy Services LimitedInventors: Devraj Goulikar, Aparna Joshi, Saurabh Das, Kamlesh Mhashilkar, Rajdeep Sarkar, Abhay Sodani, Divya Vasudevan, Vamsee Krishna Kodali
-
Publication number: 20190383385Abstract: An operating shift apparatus for a manual transmission includes: an operating lever having an upper end at which a handle is disposed and a lower end extending toward a lever box; a shift lever having a shift joint disposed at a lower end of the shift lever; a connecting lever, an upper end of which is rotatably connected with the shift lever, having a cylinder joint which is downwardly protruded; a select lever having a select groove into which the cylinder joint is accommodated, a select joint disposed at a front end of the select lever, a return protrusion which is downwardly protruded, and a guide groove which is formed at both ends thereof, wherein the lever box has a guide rail which is engaged with the guide groove; and a return spring contacting the return protrusion to return the select lever to an original position.Type: ApplicationFiled: September 10, 2018Publication date: December 19, 2019Inventors: Hari Gothra HARIDWARKAR, Aluri Vamsee KRISHNA
-
Patent number: 10294478Abstract: The present invention relates to a nucleic acid aptamer molecule that includes a domain that binds to an estrogen receptor, molecular complexes that include the nucleic acid aptamer molecule and an estrogen receptor, and constructed DMA molecules and expression systems, as well as host cells, that the contain an RNA aptamer molecule of the invention. Use of these aptamers and encoding constructs to inhibiting estrogen receptor activity in a cell and to treat estrogen receptor-positive cancers is also described.Type: GrantFiled: August 16, 2012Date of Patent: May 21, 2019Assignee: The Research Foundation for The State University of New YorkInventors: Hua Shi, Daiying Xu, Vamsee Krishna Chatakonda
-
Patent number: 10260552Abstract: A transmission cable locking device for vehicles may include a plurality of opposing locking clips rotating with respect to each other wherein the rotation determines a grip or release state of a transmission cable; a locking band provided between the locking clips and providing interconnecting tension between the locking clips; and a housing accommodating the locking clips and the locking band, and in which a hinge shaft is formed wherein the locking clips are coupled to the internal surface to rotate.Type: GrantFiled: February 5, 2018Date of Patent: April 16, 2019Assignees: Hyundai Motor Company, Kia Motors CorporationInventors: Aluri Vamsee Krishna, Eun Sik Kim, Hari Gothra Haridwarkar
-
Publication number: 20190102375Abstract: With the scale of information available today along with the existing diverse channels of communication, manual processing of information is becoming a challenge and companies across industries are under tremendous pressure to lower transactional costs. Artificial Intelligence based automation of business transactions has seen regulatory hurdles due to probabilistic nature of the outcome. The main challenge lies in processing of transactions with unstructured information. Systems and methods of the present disclosure uses deterministic as well as probabilistic approaches to maximize accuracy. The larger use of deterministic approach with configurable components and ontologies helps to improvise accuracy, precision and reduce recall. The probabilistic approach is used when there is absence of quality information or less information for learning. Also, confidence indicators are provided at attribute level of data being processed and at each decision level.Type: ApplicationFiled: March 26, 2018Publication date: April 4, 2019Applicant: Tata Consultancy Services LimitedInventors: Devraj GOULIKAR, Aparna Joshi, Saurabh Das, Kamlesh Mhashilkar, Rajdeep Sarkar, Abhay Sodani, Divya Vasudevan, Vamsee Krishna Kodali
-
Publication number: 20170238221Abstract: Methods, systems, and devices for wireless communication are described. A user equipment (UE) may determine that a number of access stratum (AS) operations or communications have failed while attempting to communicate with a cell. Based on the AS failures, the UE may deprioritize the cell. For example, based on the deprioritization, the UE may bar certain cells from selection or reselection procedures. The UE may thus attempt to select or reselect a different cell even if the cell is ranked lower based on a selection criteria or reselection criteria. In some cases, UEs may store and share historical AS failure information that may also be used to determine when to deprioritize a cell. In some cases, a group of cells may be deprioritized (e.g., a group based on frequency, network, or tracking area).Type: ApplicationFiled: February 9, 2017Publication date: August 17, 2017Inventors: Arvind Vardarajan Santhanam, Daniel Amerga, Scott Allan Hoover, Tian Mai, Arun Prasanth Balasubramanian, Muthukumaran Dhanapal, Vamsee Krishna Somavarapu, Srinivasan Balasubramanian
-
Patent number: 9388113Abstract: The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.Type: GrantFiled: October 1, 2015Date of Patent: July 12, 2016Assignee: Laurus Labs Private LimitedInventors: Venkata Sunil Kumar Indukuri, Seeta Ramanjaneyulu Gorantla, Vamsee Krishna Muppidi, Satyanarayana Chava
-
Publication number: 20160122274Abstract: The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.Type: ApplicationFiled: October 1, 2015Publication date: May 5, 2016Inventors: Venkata Sunil Kumar Indukuri, Seeta Ramanjaneyulu Gorantla, Vamsee Krishna Muppidi, Satyanarayana Chava
-
Patent number: 9303027Abstract: The present invention relates to a series of substituted compounds having the general formula (I), including their stereoisomers and/or their pharmaceutically acceptable salts. (I) Wherein A, m, R1s, R2, R3, R4 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (?) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.Type: GrantFiled: July 19, 2011Date of Patent: April 5, 2016Assignees: DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.Inventors: Pradip Kumar Sasmal, Vamsee Krishna Chintakunta, Vijay Potluri, Ish Kumar Khanna, Ashok Tehim, Mahaboobi Jaleel, Thomas Hogberg, Oystein Rist, Lisbeth Elster, Thomas Michael Frimurer, Lars-Ole Gerlach
-
Publication number: 20150327099Abstract: Methods implemented in a mobile communication device (e.g., a dual-SIM-dual-active or multi-SIM-multi-active communication device) for improving accuracy of radio-frequency (RF) output power measurements include opportunistically scheduling when a power detector takes RF output power measurements of a radio access technology (“RAT”). In various embodiments, a processor of the mobile communication device may ensure that the power detector takes an accurate RF output power measurement of the RAT by identifying an upcoming time window during which the RAT's transmit power is not artificially reduced as a result of performing transmit blanking/zeroing or artificially increased by transmissions originating from one or more other RATs operating on the device, and configuring or scheduling the power detector to take RF output power measurements of the RAT during that upcoming time window. A priority of the measured RAT may be increased in response to repeated delays in obtaining an RF output power measurement.Type: ApplicationFiled: May 6, 2014Publication date: November 12, 2015Applicant: QUALCOMM IncorporatedInventors: Francis Ming-Meng Ngai, Sai Kwok, Brian Michael George, Vamsee Krishna Babu Boda, Narendra Varma Gottimukkala, Erdogan Debe
-
Patent number: 9181256Abstract: The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.Type: GrantFiled: October 12, 2012Date of Patent: November 10, 2015Assignee: Laurus Labs Private Ltd.Inventors: Venkata Sunil Kumar Indukuri, Seeta Ramanjaneyulu Gorantla, Vamsee Krishna Muppidi, Satyanarayana Chava
-
Patent number: 9077419Abstract: Methods and apparatus for selecting one or more suitable antennas for use during power-up/initial acquisition and out of service modes are disclosed. In some examples, initial system acquisition may be performed for a particular receive circuit utilizing a selected one of a first antenna or a second antenna, based on a channel characteristic, such as an automatic gain control (AGC) value corresponding to a received signal energy utilizing either of the antennas. In another example, initial system acquisition utilizing either a receive diversity determination algorithm or an antenna switching determination algorithm may be performed based on a channel characteristic, such as an AGC value corresponding to a received signal energy utilizing one of the antennas coupled to one of the receive circuits.Type: GrantFiled: October 29, 2013Date of Patent: July 7, 2015Assignee: QUALCOMM IncorporatedInventors: Troy Russell Curtiss, Vamsee Krishna Somavarapu, Gregory Robert Lie, Jun Hu, Alexey Semjonovs, Sundararaman Kunchithapatham, Stanley Suyi Tsai
-
Publication number: 20140329483Abstract: Methods and apparatus for selecting one or more suitable antennas for use during power-up/initial acquisition and out of service modes are disclosed. In some examples, initial system acquisition may be performed for a particular receive circuit utilizing a selected one of a first antenna or a second antenna, based on a channel characteristic, such as an automatic gain control (AGC) value corresponding to a received signal energy utilizing either of the antennas. In another example, initial system acquisition utilizing either a receive diversity determination algorithm or an antenna switching determination algorithm may be performed based on a channel characteristic, such as an AGC value corresponding to a received signal energy utilizing one of the antennas coupled to one of the receive circuits.Type: ApplicationFiled: October 29, 2013Publication date: November 6, 2014Applicant: QUALCOMM IncorporatedInventors: Troy Russell Curtiss, Vamsee Krishna Somavarapu, Gregory Robert Lie, Jun Hu, Alexey Semjonovs, Sundararaman Kunchithapatham, Stanley Suyi Tsai
-
Publication number: 20140073791Abstract: The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.Type: ApplicationFiled: October 12, 2012Publication date: March 13, 2014Applicant: LAURUS LABS PRIVATE LIMITEDInventors: Venkata Sunil Kumar Indukuri, Seeta Ramanjaneyulu Gorantla, Vamsee Krishna Muppidi, Satyanarayana Chava
-
Publication number: 20130303525Abstract: The present invention relates to a series of substituted compounds having the general formula (I), including their stereoisomers and/or their pharmaceutically acceptable salts. (I) Wherein A, m, R1s, R2, R3, R4 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (?) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.Type: ApplicationFiled: July 19, 2011Publication date: November 14, 2013Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY;S LABORATORIES LTD.Inventors: Pradip Kumar Sasmal, Vamsee Krishna Chintakunta, Vijay Potluri, Ish Kumar Khanna, Ashok Tehim, Mahaboobi Jaleel, Thomas Hogberg, Oystein Rist, Lisbeth Elster, Thomas Michael Frimurer, Lars-Ole Gerlach
-
Publication number: 20110213159Abstract: Celecoxib crystalline Form Ill substantially free of celecoxib crystalline Forms I and II and a process for its preparation.Type: ApplicationFiled: February 28, 2011Publication date: September 1, 2011Inventors: Vamsee Krishna Muppidi, Srinivasulu Rangineni, Naga Kiran Duggirala, Srividya Ramakrishnan, Arjun Kumar Tummala
-
Patent number: 7622486Abstract: The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.Type: GrantFiled: September 23, 2005Date of Patent: November 24, 2009Assignee: Reddy US Therapeutics, Inc.Inventors: Manojit Pal, Christopher W. Alexander, Ish Khanna, Javed Iqbal, Ram Pillarisetti, Santanu Maitra, Gayla W. Roberts, Lavanya Sagi, Chintakunta Vamsee Krishna, Jennepalli Sreenu
-
Patent number: 6177439Abstract: Novel water soluble C-ring analogues of 20(S)-camptothecin having the general formula 1, All the compounds of the formula 1 are prepared from the compounds of the general formula 2 having 20(S)-chiral carbon where R1 to R5 have the meaning given above. The compounds of the formula 1 possess potent anti-cancer and anti-viral properties.Type: GrantFiled: December 19, 1996Date of Patent: January 23, 2001Assignees: Reddy's Research Foundation, Reddy-Cheminor, Inc.Inventors: Subrahmanyam Duvvuri, Venkateswarlu Akella, Sharma Manohara Vedula, Sastry V. R. S. Thungathurthi, Vamsee Krishna Chintakunta, Shobha Madabhushi
-
Patent number: 5887058Abstract: A telecommunications switch (12) includes a dial plan database (300) used for creating, identifying, and verifying dial plan codes and dialing sequences of a desire dial plan (100). The dial plan (100) is created through a craft terminal (201) that communicates with a craft interface (200) of the telecommunications switch (12). The telecommunications switch (12) uses dial plans created and stored within the dial plan database (300) in performing a digit parsing routine. The digit parsing routine identifies dial plan codes and dialing sequences through digit collection by systematically eliminating possible dial plan codes until one is identified. The identified dial plan code is processed by performing valid or error actions associated with the identified dial plan code. The digit parsing routine continues with an incoming call until it has been appropriately handled and awaits for the next incoming call digits to be received.Type: GrantFiled: December 31, 1996Date of Patent: March 23, 1999Assignee: Alcatel USA Sourcing, L.P.Inventors: Ramesh Kammath, Mulugu S. Kumar, Santharaj Kuppuswamy, Vamsee Krishna, Kumar A. Basavaraj, Balijepalli Ramakrishna, Bradford A. Zavattari, James R. Daniel, Steven C. Loss, Ronald S. Goldman, Chandrashekar B. Benakatti